$AMFN

American Fusion, Inc.

CIK:0000096664|SEC Filings

CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2026	Jun. 30, 2025
Income Statement [Abstract]
Revenue	$ 58,000		$ 58,000
Cost of revenue	50,000		50,000
Gross profit	8,000		8,000
Selling, general and administrative expenses	1,253,180		1,885,763	100,000
Loss from operations	(1,245,180)		(1,877,763)	(100,000)
Other income (expense)
Interest expense	(30,028)	(55,319)	(67,195)	(55,319)
Total other expense	(30,028)	(55,319)	(67,195)	(55,319)
Net loss	$ (1,275,208)	$ (55,319)	$ (1,944,958)	$ (155,319)
Weighted Average Shares Outstanding - Basic	2,113,138,685	2,625,061,314	2,388,774,665	2,625,061,314
Weighted Average Shares Outstanding - Diluted	2,113,138,685	2,625,061,314	2,388,774,665	2,625,061,314
Weighted average loss per share - basic	$ (0.00)	$ (0.00)	$ (0.00)	$ (0.00)
Weighted average loss per share - diluted	$ (0.00)	$ (0.00)	$ (0.00)	$ (0.00)

CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025
Cash flows from operating activities:
Net loss	$ (1,944,958)	$ (155,319)
Adjustments to reconcile net loss to net cash used in operating activities:
Convertible notes payable – related party issued for consulting services		100,000
Stock-based compensation	881,526
Accrued interest on convertible notes payable – related party	41,231	29,140
Accrued interest on litigation liability	25,964	26,179
Change in operating assets and liabilities:
Accounts receivable	(58,000)
Prepaid assets	(10,870)
Accounts payable and accrued expenses	22,395
Net cash used in operating activities	(1,042,712)
Cash flows used in investing activities:
Capitalized intangible assets	(48,472)
Net cash used in investing activities	(48,472)
Cash flows from financing activities:
Proceeds from issuance of prefunded warrants	943,000
Proceeds from issuance of security purchase agreements - units	225,000
Net cash provided by financing activities	1,168,000
Net increase in cash and cash equivalents	76,816
Cash and cash equivalents, beginning of period	2,525	2,525
Cash and cash equivalents, end of period	79,341	2,525
Cash paid during the period for:
Interest
Income taxes
Non-cash investing and financing activities:
Convertible notes payable – related party conversion to common stock	$ 25,000

CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($)	Jun. 30, 2026	Dec. 31, 2025
Current assets:
Cash and cash equivalents	$ 79,341	$ 2,525
Accounts receivable	58,000
Prepaid expenses	10,870
Total current assets	148,211	2,525
Intangible assets	48,472
Total assets	196,683	2,525
Current liabilities:
Accounts payable and accrued expenses	669,567	58,500
Convertible notes payable – related party	489,754	473,523
Litigation liability	697,341	671,377
Total current liabilities	1,856,662	1,203,400
Total Liabilities	1,856,662	1,203,400
Stockholders’ deficit:
Preferred Stock, Series A, par $0.001; 20,000,001 authorized; 1 issued
Common Stock, par $0.001; 1.8B authorized; 1,000,000 issuable at June 30, 2026; 1,641,801,029 issued and 1,619,034,363 outstanding at June 30, 2026 and 2,939,061,314 issued and outstanding at December 31, 2025	1,641,801	2,939,061
Common stock issuable
Additional paid-in capital	7,604,998	16,216,112
Accumulated deficit	(10,906,778)	(20,356,048)
Treasury Stock, 22,766,666 and 0 shares issued at June 30, 2026 and December 31, 2025, respectively
Total stockholders’ deficit	(1,659,979)	(1,200,875)
Total liabilities and stockholders’ deficit	$ 196,683	$ 2,525